Biotech Report Says IP Spurs Innovation
ananyo writes "A report presented at the 2012 BIO International Convention in Boston, Massachusetts suggests that patents do not stifle progress when they occur at early phases of research, as some have suggested. Over the past decade, increases in patents have been matched by growth in the biotech and pharmaceutical sectors in India, Brazil, Singapore and other countries with emerging economies. The strength of patent rights can be quantified in an index ranging from 0 (no patent rights) to 5 (very strong). Over time, the countries that U.S. biotech and pharmaceutical companies have invested in have moved up the IP barometer, the report (PDF) says."
Let's all focus on software patents rather than all patents in general. The argument is much more cut and dry. If we focus all our energy on getting rid of software patents, I think it would be more beneficial than trying to reform all patent law. Once we've gotten rid of software patents, then we can move to reforming the patent law in regards to areas that are much more gray.
The entire premise of the article is that patents == innovation, and thus, more patents indicate more innovation. As an example, the article mentions that:
Similarly, after Taiwan instituted a rule about IP based on government-funded findings, the Bayh-Dole Act, university patenting increased by 354% between 2004 and 2009.
Clearly, the increase was due to an acceleration of innovative research and not because of an act that made previously un-patentable research now available for patents.
"They that can give up essential liberty to obtain a little temporary safety deserve neither liberty nor safety."